EVENTS

Australasian College of Toxicology and Risk Assessment’s (ACTRA) Annual Scientific Meeting 2021

ZeClinics will contribute to the ACTRA Annual Scientific Meeting with an oral presentation of our Co-founder and CDD Javier Terriente

ZECLINICS NEWS

ZeClinics and University of Messina enter into agreement to launch a joint Industrial PhD Program in Veterinary Sciences

EVENTS

Annual Meeting of the Japanese Society of Toxicology (JSOT)

ZeClinincs will attend the meeting to present its work on standardization of developmental neurotoxicity assessment.

model-human-glioma-in-zebrafish ZECLINICS NEWS

Conclusion of ZF-Glioma project

EVENTS

International Zebrafish Conference 2021

ZeClinics is presenting in IZFC 2021.

EVENTS

BIO International Convention 2021

ZeClinics is participating in the BIO Digital 2021.

EVENTS

23rd European Congress of Endocrinology (e-ECE 2021)

We are happy to announce ZeClinics participation in e-ECE 2021.

MEDIA

ZeClinics podría dar vida a una nueva ‘spin off’ a partir del año que viene

ZeCardio Therapeutics busca cinco millones para acelerar en investigación cardiovascular

MEDIA

9 start-ups españolas seleccionadas en el programa Bridgehead de EIT Health

ZeClinics es una de las 3 startups españolas seleccionadas en el programa Bridgehead Global, que permitirá la internalización de sus proyectos a nivel mundial.

EVENTS

Virtual Conference SETAC Europe 31st Annual Meeting

We are pleased to announce ZeClinics involvement in SETAC Europe 2021.

EVENTS

Virtual 2021 SOT Annual Meeting and ToxExpo

ZeClinics is participating as exhibitor at the largest Toxicology event

Logo_cardiomyo_project ZECLINICS NEWS

ZeClinics, Amsterdam UMC and Taros Chemicals join forces to boost drug discovery for cardiomyopathies

MEDIA

Por qué es importante coger el tren de la innovación con CRISPR

Cáncer, enfermedades infecciosas, genéticas, alimentación sostenible para todos, plantas resistentes a la sequía, bioeconomía o alimentación funcional. Estas son algunas de las aplicaciones de CRISPR

MEDIA

ERS Genomics and ZeClinics team up on gene-edited zebrafish disease models

ZeClinics and ERS Genomics sign CRISPR/Cas9 license agreement.

MEDIA

ERS Genomics and ZeClinics sign CRISPR/Cas9 license agreement

ERS Genomics and ZeClinics sign CRISPR/Cas9 license agreement

MEDIA

ERS Genomics and ZeClinics sign CRISPR/Cas9 license agreement

ZeClinics gains access to ERS Genomics’ CRISPR/Cas9 patent portfolio.